23rd Feb 2017 07:00
23 February 2017
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Notice of Results
The neuroscience digital health company Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG) will be reporting its preliminary results for the twelve months ended 31 December 2016 on Wednesday 29 March 2017.
Enquiries
Cambridge Cognition Holdings PLC Steven Powell, Chief Executive Officer Noah Konig, Director of Marketing and Communications |
Tel: 01223 810 700 |
finnCap Ltd (NOMAD and Joint Broker) Geoff Nash / Simon Hicks Alice Lane | Tel: 020 7220 0500 (Corporate Finance) (Corporate Broking) |
Dowgate Capital Stockbrokers Limited David Poutney / James Serjeant | Tel: 01293 517 744
|
Notes to editors
About Cambridge Cognition Holdings PLC
Cambridge Cognition is a neuroscience digital health company specialising in the precise measurement of clinical outcomes in neurological disorders. The Company develops and markets validated near patient assessment products using cognition as a biomarker to improve understanding, diagnosis and treatment in brain health worldwide.
Partners include the world's leading drug development companies, academic institutions and public-private health organisations.
www.cambridgecognition.com @CANTABconnect [email protected]
Related Shares:
Cambridge Cog